SCHEMBL23348398

SCHEMBL23348398

CC(C)(C)c1ccc2c(c1)c1ccc(-c3ccccc3)cc1n2-c1cc(-c2ccccc2)cc(-n2c3ccc(C(C)(C)C)cc3c3ccc(-c4ccccc4)cc32)c1C#N

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.35
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
SERPINE1 P05121 2/20 0.32
NRP1 O14786 1/20 0.32
GRM2 Q14416 1/20 0.32
MAPT P10636 2/20 0.32
KDM4E B2RXH2 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
KDM4A O75164 1/20 0.32
KDM5B Q9UGL1 1/20 0.32
DHODH Q02127 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HIF1A Q16665 1/20 0.32
DNMT1 P26358 3/20 0.31
ALDH1A1 P00352 1/20 0.31
GRIA2 P42262 1/20 0.31
GRIA4 P48058 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23348297 0.95 KIF11 (0.34) KIF11RXRARXRBSERPINE1NRP1
SCHEMBL23348409 0.95 KIF11 (0.34) KIF11SERPINE1NRP1MAPTKDM4E
SCHEMBL23348464 0.95 SQOR (0.35) KIF11RXRARXRBSERPINE1KDM4E
SCHEMBL23348416 0.94 PGR (0.35) KIF11RXRARXRBSERPINE1GRIA2
SCHEMBL23348323 0.93 SMN1; SMN2 (0.39) KIF11RXRARXRBSERPINE1NRP1
SCHEMBL21840875 0.93 KIF11 (0.37) KIF11RXRARXRBSERPINE1NRP1
SCHEMBL23348322 0.92 KIF11 (0.33) KIF11RXRARXRBSERPINE1NRP1
SCHEMBL23348320 0.91 ALDH1A1 (0.36) KIF11RXRARXRBSERPINE1MAPT
SCHEMBL23348420 0.90 SERPINE1 (0.33) KIF11RXRARXRBSERPINE1NRP1
SCHEMBL23348520 0.89 KDM5B (0.36) MAPTKDM4EKDM4AKDM5BSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210139425-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-05-13 US disclosed
US-9527885-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2016-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139425-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CCND2, CCND1, CRY1 KIF11 1724/4885RXRA 4041/4885RXRB 4278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.